BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31761612)

  • 1. Longitudinal patterns of cost and utilization of medicare beneficiaries with bladder cancer.
    Sloan FA; Yashkin AP; Akushevich I; Inman BA
    Urol Oncol; 2020 Feb; 38(2):39.e11-39.e19. PubMed ID: 31761612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cost to Medicare of Bladder Cancer Care.
    Sloan FA; Yashkin AP; Akushevich I; Inman BA
    Eur Urol Oncol; 2020 Aug; 3(4):515-522. PubMed ID: 31412015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
    Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
    Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization.
    Xu WY; Wickizer TM; Jung JK
    BMC Health Serv Res; 2019 Jun; 19(1):392. PubMed ID: 31208422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonoperative care to manage sacroiliac joint disruption and degenerative sacroiliitis: high costs and medical resource utilization in the United States Medicare population.
    Ackerman SJ; Polly DW; Knight T; Holt T; Cummings J
    J Neurosurg Spine; 2014 Apr; 20(4):354-63. PubMed ID: 24527824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Care Utilization and Cost Outcomes of a Comprehensive Dementia Care Program for Medicare Beneficiaries.
    Jennings LA; Laffan AM; Schlissel AC; Colligan E; Tan Z; Wenger NS; Reuben DB
    JAMA Intern Med; 2019 Feb; 179(2):161-166. PubMed ID: 30575846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
    Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical model of cost of bladder cancer in the elderly.
    Cooksley CD; Avritscher EB; Grossman HB; Sabichi AL; Dinney CP; Pettaway C; Elting LS
    Urology; 2008 Mar; 71(3):519-25. PubMed ID: 18342201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care costs and utilization prior to diagnosis of antineutrophil cytoplasmic antibody vasculitis in Medicare beneficiaries.
    Huang SP; Li X; Cao B; Nguyen JT; Robinson JE; Derebail VK; Hogan SL; Thorpe CT
    J Manag Care Spec Pharm; 2022 Nov; 28(11):1292-1303. PubMed ID: 36282932
    [No Abstract]   [Full Text] [Related]  

  • 10. How much do persons with Alzheimer's disease cost Medicare?
    Taylor DH; Sloan FA
    J Am Geriatr Soc; 2000 Jun; 48(6):639-46. PubMed ID: 10855599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
    Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
    JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.
    Riley GF; Potosky AL; Lubitz JD; Kessler LG
    Med Care; 1995 Aug; 33(8):828-41. PubMed ID: 7637404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Trends in Medicare Payments for Outpatient Cancer Care at the End of Life.
    Mantz CA; Yashar CM; Bajaj GK; Sandler HM
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):729-735. PubMed ID: 36657498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic impact of epilepsy and the cost of nonadherence to antiepileptic drugs in older Medicare beneficiaries.
    Ip Q; Malone DC; Chong J; Harris RB; Labiner DM
    Epilepsy Behav; 2018 Mar; 80():208-214. PubMed ID: 29414554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare Claims Paid by the Federal Black Lung Benefits Program: US Medicare Beneficiaries, 1999 to 2016.
    Kurth L; Casey M; Schleiff P; Halldin C; Mazurek J; Blackley D
    J Occup Environ Med; 2019 Dec; 61(12):e510-e515. PubMed ID: 31651595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic value of orthotic and prosthetic services among medicare beneficiaries: a claims-based retrospective cohort study, 2011-2014.
    Dobson A; Murray K; Manolov N; DaVanzo JE
    J Neuroeng Rehabil; 2018 Sep; 15(Suppl 1):55. PubMed ID: 30255806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and Costs for Women After Breast Cancer: Preparing for Improved Survivorship of Medicare Beneficiaries.
    Yashkin AP; Greenup RA; Gorbunova G; Akushevich I; Oeffinger KC; Hwang ES
    JCO Oncol Pract; 2021 Apr; 17(4):e469-e478. PubMed ID: 32692618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016.
    Mukherjee K; Small W; Duszak R
    Brachytherapy; 2022; 21(1):12-21. PubMed ID: 34380592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Real-World Medicare Costs of Alzheimer Disease: Considerations for Policy and Care.
    Pyenson B; Sawhney TG; Steffens C; Rotter D; Peschin S; Scott J; Jenkins E
    J Manag Care Spec Pharm; 2019 Jul; 25(7):800-809. PubMed ID: 31232206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment patterns among Medicare beneficiaries newly diagnosed with lumbar spinal stenosis.
    Chen E; Tong KB; Laouri M
    Spine J; 2010 Jul; 10(7):588-94. PubMed ID: 20381431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.